DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 58 filers reported holding DOVA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $97,000 | +385.0% | 5,400 | -48.6% | 0.01% | +350.0% |
| Q2 2019 | $20,000 | +400.0% | 10,500 | +2000.0% | 0.00% | – |
| Q1 2019 | $4,000 | -42.9% | 500 | -58.3% | 0.00% | – |
| Q4 2018 | $7,000 | +75.0% | 1,200 | -78.6% | 0.00% | – |
| Q3 2018 | $4,000 | -86.7% | 5,600 | +9.8% | 0.00% | -100.0% |
| Q2 2018 | $30,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,125,851 | $23,693,000 | 0.90% |
| Broadfin Capital, LLC | 351,800 | $2,667,000 | 0.35% |
| Birchview Capital, LP | 40,000 | $303,000 | 0.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 185,000 | $1,402,000 | 0.16% |
| Fosun International Ltd | 261,780 | $1,984,000 | 0.12% |
| Spark Investment Management LLC | 61,100 | $463,000 | 0.03% |
| Candriam S.C.A. | 233,200 | $1,768,000 | 0.03% |
| GW&K Investment Management, LLC | 178,536 | $1,353,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 20,613 | $156,000 | 0.01% |
| Point72 Hong Kong Ltd | 1,456 | $11,000 | 0.01% |